BG49717A3 - Метод за получаване на хирудин - Google Patents

Метод за получаване на хирудин

Info

Publication number
BG49717A3
BG49717A3 BG077615A BG7761586A BG49717A3 BG 49717 A3 BG49717 A3 BG 49717A3 BG 077615 A BG077615 A BG 077615A BG 7761586 A BG7761586 A BG 7761586A BG 49717 A3 BG49717 A3 BG 49717A3
Authority
BG
Bulgaria
Prior art keywords
hirudin
mature
obtaining
obtaining hirudin
yeast
Prior art date
Application number
BG077615A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gerard Loison
Paul Tolstoshev
Yves Lemoine
Jean-Pierre Lecoco
Original Assignee
Transgene S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene S.A. filed Critical Transgene S.A.
Publication of BG49717A3 publication Critical patent/BG49717A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Instructional Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
BG077615A 1985-05-02 1986-12-19 Метод за получаване на хирудин BG49717A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8506672A FR2593518B1 (fr) 1985-05-02 1985-05-02 Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
PCT/FR1986/000153 WO1986006406A1 (fr) 1985-05-02 1986-05-02 Vecteurs d'expression et de secretion de l'hirudine par les levures transformees

Publications (1)

Publication Number Publication Date
BG49717A3 true BG49717A3 (bg) 1992-01-15

Family

ID=9318888

Family Applications (1)

Application Number Title Priority Date Filing Date
BG077615A BG49717A3 (bg) 1985-05-02 1986-12-19 Метод за получаване на хирудин

Country Status (22)

Country Link
EP (1) EP0200655B1 (de)
JP (2) JP2580141B2 (de)
KR (1) KR870700234A (de)
AT (1) ATE121778T1 (de)
AU (1) AU600667B2 (de)
BG (1) BG49717A3 (de)
CA (1) CA1341501C (de)
CZ (1) CZ282928B6 (de)
DE (1) DE3650306T2 (de)
DK (1) DK174837B1 (de)
ES (1) ES8703930A1 (de)
FI (1) FI104635B (de)
FR (2) FR2593518B1 (de)
HU (1) HU202919B (de)
IE (1) IE67136B1 (de)
MC (1) MC1785A1 (de)
NO (1) NO302375B1 (de)
PL (1) PL155074B1 (de)
PT (1) PT82490B (de)
RU (1) RU1774950C (de)
WO (1) WO1986006406A1 (de)
ZA (1) ZA863261B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
FR2607516B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs perfectionnes d'expression d'un variant de l'hirudine dans les levures, procede et produit obtenu
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
FR2611723B1 (fr) * 1987-02-27 1989-09-08 Transgene Sa Vecteur d'expression d'adn recombinant codant pour l'hirudine, cultures de cellules de mammiferes infectees ou transformees, procede de preparation de l'hirudine et proteine obtenue
FI896261A7 (fi) * 1987-06-24 1989-12-22 Novo Nordisk As Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
AU633020B2 (en) * 1988-07-23 1993-01-21 Novozymes Delta Limited New secretory leader sequences
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
CA2000887A1 (en) * 1988-11-01 1990-05-01 Cecilia S.L. Ku Thromboresistant materials and methods for making same
US5053453A (en) * 1988-11-01 1991-10-01 Baxter International Inc. Thromboresistant materials and methods for making same
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
EP1031628A1 (de) * 1992-09-04 2000-08-30 Novartis AG Verfahren zur Herstellung von Proteaseinhibitoren
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
IL114160A (en) * 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
DE19529997C1 (de) * 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
ZA9610456B (en) * 1995-12-20 1997-06-20 Novo Nordisk As N-terminally extended proteins expressed in yeast
EP0787569B1 (de) 1996-01-31 2002-10-02 Sumitomo Bakelite Company Limited Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
US6265204B1 (en) 1997-01-17 2001-07-24 Genencor International, Inc. DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
DE10149678A1 (de) 2001-10-09 2009-03-12 Novel Science International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
DE10301255A1 (de) 2003-01-15 2004-07-29 Cpi Creative Pharma International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382547D1 (de) * 1983-01-12 1992-05-27 Chiron Corp Sekretorische expression in eukaryoten.
AU572125B2 (en) * 1983-03-17 1988-05-05 Mabco Limited Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
WO1984004330A1 (en) * 1983-04-22 1984-11-08 Amgen Secretion of exogenous polypeptides from yeast
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
JPS6041487A (ja) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
JPS59227899A (ja) * 1983-05-25 1984-12-21 チロン・コ−ポレイシヨン 成長ホルモン放出因子の製造方法
WO1985004418A1 (fr) * 1984-03-27 1985-10-10 Transgene S.A. Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees

Also Published As

Publication number Publication date
FR2601383A2 (fr) 1988-01-15
HU202919B (en) 1991-04-29
FI865303A0 (fi) 1986-12-23
WO1986006406A1 (fr) 1986-11-06
PT82490A (fr) 1986-05-01
PL155074B1 (en) 1991-10-31
JPS62502661A (ja) 1987-10-15
PT82490B (pt) 1988-03-03
CZ282928B6 (cs) 1997-11-12
DK174837B1 (da) 2003-12-15
FI865303L (fi) 1986-12-23
FR2593518B1 (fr) 1989-09-08
AU5778786A (en) 1986-11-18
JP2779930B2 (ja) 1998-07-23
RU1774950C (ru) 1992-11-07
HK1006183A1 (en) 1999-02-12
IE67136B1 (en) 1996-03-06
AU600667B2 (en) 1990-08-23
DE3650306T2 (de) 1995-10-12
KR870700234A (ko) 1987-05-30
DK634386D0 (da) 1986-12-30
DK634386A (da) 1986-12-30
ZA863261B (en) 1986-12-30
FR2601383B2 (fr) 1989-12-22
ATE121778T1 (de) 1995-05-15
CA1341501C (fr) 2006-03-14
FI104635B (fi) 2000-03-15
EP0200655B1 (de) 1995-04-26
JPH09103295A (ja) 1997-04-22
DE3650306D1 (de) 1995-06-01
NO865336L (no) 1987-03-02
MC1785A1 (fr) 1987-09-02
ES8703930A1 (es) 1987-03-16
EP0200655A1 (de) 1986-11-05
NO302375B1 (no) 1998-02-23
FR2593518A1 (fr) 1987-07-31
ES555121A0 (es) 1987-03-16
CZ321786A3 (en) 1997-07-16
JP2580141B2 (ja) 1997-02-12
HUT42131A (en) 1987-06-29
IE861183L (en) 1986-11-02

Similar Documents

Publication Publication Date Title
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
FR2656337B1 (fr) Electrode generatrice d'oxygene et procede pour sa preparation.
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
HUT40440A (en) Process for production of new alpha /-2-i-oxo-2,4,5,6,7a-hexahydro-tieno /3,2-c/-pirid-5-il/ derivatives of phenil acedit acid
PT82490A (fr) Procede de preparation de vecteurs d'expression et de secretion de l'hirudine par les levures transformees
HUT47261A (en) Process for production of new tiasole-derivatives effecting on the cholinerg-system and medical compositions containing these substances
IT8523299A0 (it) Derivati. processo per la preparazione di (2,2)-paraciclofano e suoi
EP0789588A4 (de) Verfahren zur herstellung eines arzneimittels zur behandlung des sekundärimmunmangels
GR860571B (en) Labdan-derivatives process for their preparation and their use as medicaments
BG35465A3 (en) Method for preparing derivatives of 1-(cyclohexyl)-4-aryl-4- piperidine carbonic acid
HUT46907A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing such substances
HUT47259A (en) Process for production of tetrasole-derivatives decreasing the patalogically high colestherin-level of blood
IT1138511B (it) Procedimento per la produzione di un concentrato spinto di fattore viii(ahf)
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
FR2607517B2 (fr) Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
HU911811D0 (en) Process for the production of acylized alpha, omega-amino-alcoholic derivatives and for using them in pesticide substances
ZA869054B (en) Production of cholecalciferol derivatives and novel intermediates used therefor
IT8523289A0 (it) Composizione liquida e polimerizzabile per la produzionedi sostituiti di vetri ottici.
CS274677B2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
ES8700652A1 (es) Un metodo de preparar n-4-(3-aminopropil)-aminobutil-2,2-di-hidroxietanoamida
DE3171100D1 (en) Process for separation of products containing propolis and products containing propolis
ZA857721B (en) Process for treatment of rheumatic diseases
RO87709A (ro) Procedeu pentru prepararea unor 1,1-alcandioli-carboxilati
IL77661A (en) Process for the preparation of 4,4-azetidinones,and novel intermediates thereof
GR3001052T3 (en) Novel 16,17-acetalsubstituted pregnane-21-oic acid derivatives, process for the preparation thereof and pharmaceutical preparation containing them